HIGH WYCOMBE, England, May 24, 2011 /PRNewswire/ --
- To view a short video about Schizophrenia24x7 please visit: http://www.brainshark.com/janssencns/Schizophrenia24x7
Schizophrenia24x7.com is a new, interactive website featuring helpful resources, information and interactive tools for people affected by schizophrenia.
The website, developed by Janssen, has already received a stamp of approval from patient focus groups. Ron Peponis of In A Nutshell Communications, a user group which helps to link UK-based organisations and individuals involved in health and social care together through social media, worked with patients to review the Schizophrenia24x7 website content. He said, "The feedback we received from those involved in reviewing the site has been extremely positive, and we greatly valued their input. After all this is a website for people affected by schizophrenia and we wanted to ensure it was as useful and relevant to them as possible."
Schizophrenia24x7 includes many practical resources such as a digital patient diary, which allows patients to record their experiences and feelings. This feature is important, as signs of improvement in people with schizophrenia can often be small and happen very gradually, therefore they may be missed. This can lead to poor motivation, as progress is not often recognised. The diary helps patients monitor small changes, and to notice when they are getting better. In addition, it allows patients to follow the relationship between their medication, how they are feeling and daily events in their lives, which shows patients that taking their medication can improve their symptoms.
The talking to your doctor section includes 'top tips' for patients and carers about how to have a useful discussion with their doctor about their illness and how they feel. There is also a downloadable questionnaire, which patients can print out and take with them to their next consultation.
Schizophrenia24x7 also features a patient art gallery, showcasing the creative talents of people who have experienced mental distress, provided by Breakthrough Art, an organisation that promotes positive mental health through the creative arts. The gallery offers a downloadable 'wallpaper of the week' as well as a 'picture of the month' selected by Angie Russell, Co-Director of Breakthrough Art.
Schizophrenia is a chronic, severe and disabling brain disorder that seriously impairs a person's ability to think clearly, relate to others and to function productively in society. It is relatively common and the prevalence is similar around the world; one person in every 100 will develop schizophrenia before they reach the age of 45.
For further information please visit: http://www.brainshark.com/janssencns/Schizophrenia24x7 or http://www.schizophrenia24x7.com
Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including neuroscience (e.g. schizophrenia, dementia and pain), oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), infectious disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes). Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. More information can be found at http://www.janssen.co.uk.
[1.] American Psychiatric Association. Am J Psychiatry 1997; 154:4.